Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep743 | Pituitary and Neuroendocrinology | ECE2020

Central hypothyroidism as an adverse effect of bexarotene treatment for cutaneous T-cell lymphoma

Felder Susan , Zechmann Stefan , Baur Katharina , Seelig Eleonora , Christ Emanuel , Holbro Andreas , Potlukova Eliska

Introduction: Central hypothyroidism is rare, estimated to occur in 1:20,000 to 1:80,000 in the general population. Pituitary mass lesions and adverse effects of their treatment are the most common causes of central hypothyroidism. In recent years, the incidence of pituitary hormonal deficiencies as adverse effects of novel molecular targeting anticancer drugs has risen sharply. Especially checkpoint inhibitors are associated with partial or complete hypopituitarism. In this r...

ea0063p714 | Pituitary and Neuroendocrinology 2 | ECE2019

Low arginine vasopressin levels in patients with central diabetes insipidus is not associated with anaemia

Morin Benedict , Winzeler Bettina , Refardt Julie , Imber Cornelia , Fenske Wiebke , Sailer Clara , Holbro Andreas , Christ-Crain Mirjam

Background: Arginine vasopressin (AVP) is released upon osmotic stimulation or hypovolemia in order to maintain water balance. A recent study showed a role of AVP in haematopoiesis by stimulating red blood cell precursors, suggesting a higher risk of anaemia in patientis with AVP deficiency. The aim of this study was to explore the effect of low AVP levels in patients with central diabetes insipidus (cDI) and primary polydipsia (PP) on haemoglobin and the prevalence of anaemia...